INVIVOID

What this means for you

Not registered yet, but its 13 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79420740

Mark type

Stylized text

Filed

13 Feb 2025

Attorney of record

Sean K. Owens

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for personalized cancer medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food, and other preparations for destroying vermin, fungicides, herbicides; reagent paper for medical purposes; biological tissue cultures for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological culture mediums for medical purposes; diagnostic media for bacteriological cultures for medical purposes; stem cells for medical purposes; biological preparations for the treatment of cancer for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; empty capsules for pharmaceuticals; semen for artificial insemination; cell culture media for medical purposes for use in toxicity tests, drug discovery research, cultured foods, regenerative medicine and personalized medicine in the fields of cancer and 3D cell culture.
• Class 009 — Scientific and electric apparatus: Laboratory apparatus and instruments, namely, incubators for bacteria culture; photographic machines and apparatus, namely, cameras; optical machines and apparatus, namely, scanners and microscopes; measuring or testing machines and instruments, namely, electronic apparatus for electrophysiological measurement and testing of cells; personal digital assistants; computer programs, namely, software as a medical device (SaMD), downloadable, for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; computer software, recorded, for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; computer software applications, downloadable, for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; recorded computer operating programs; computer programs, downloadable, for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; computer software platforms, recorded and downloadable, for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; downloadable graphics for mobile phones; downloadable emoticons for mobile phones; downloadable image files for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; recorded video discs and video tapes for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; electronic publications, namely, downloadable newsletters in the nature of personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; telepresence robots.
• Class 042 — Scientific and technological services: Designing of machines, apparatus, instruments or systems composed of such machines, apparatus and instruments; computer programming; information technology (IT) support services, namely, troubleshooting of computer software and hardware problems; artificial intelligence technology consultancy; computer system design; development of computer platforms; recovery of computer data; data security consultancy; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; culturing of cells for others for scientific research purposes; conducting technical project scientific feasibility studies; rental of measuring apparatus; rental of computers; providing temporary use of online non-downloadable computer programs on data networks for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; rental of web servers; rental of computer software for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; platform as a service (PaaS) services featuring software for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; software as a service (SaaS) services featuring software for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; providing virtual computer systems through cloud computing; server hosting; electronic data storage; rental of laboratory apparatus and instruments; design and testing of new products relating to cell culture for use in toxicity tests, drug discovery research, cultured foods, regenerative medicine and personalized medicine in the fields of cancer and 3D cell culture; research services for the development of new products relating to cell culture for use in toxicity tests, drug discovery research, cultured foods, regenerative medicine and personalized medicine in the fields of cancer and 3D cell culture.

Owner

• TOPPAN Holdings Inc., JP

Prosecution history

• 24 Feb 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 24 Feb 2026 — FINAL REFUSAL E-MAILED
• 24 Feb 2026 — FINAL REFUSAL WRITTEN
• 12 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 12 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 12 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 05 Sept 2025 — REFUSAL PROCESSED BY IB
• 16 Aug 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 15 Aug 2025 — REFUSAL PROCESSED BY MPU
• 04 Jul 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 03 Jul 2025 — NON-FINAL ACTION WRITTEN
• 01 Jul 2025 — ASSIGNED TO EXAMINER
• 08 Apr 2025 — APPLICATION FILING RECEIPT MAILED
• 08 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 03 Apr 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB